Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Rhyner

Clinical Cardiac Electrophysiology Asheville, NC Medical Doctor

NPI 1104089002 CMS profile 1333827

5 Vanderbilt Park Dr, Asheville, NC 28803

Open in the dashboard

General payments

$168,307

540 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$163,908 paid to institutions, not to them · program years 2019–2025

Through program year 2025, John Rhyner of Asheville, NC is reported in the CMS Open Payments database as having received $168,307 across 540 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $163,908 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $25,297 92
2024 General $13,917 83
2023 General $25,266 113
2022 General $23,258 58
2021 General $22,120 52
2020 General $19,371 57
2019 General $39,079 85

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Rhyner
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to John Rhyner were reported at $25,297. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year John Rhyner Clinical Cardiac Electrophysiology median Middle half National median
2019 $39,079 $2,361 $585–$8,260 $163
2020 $19,371 $993 $247–$4,351 $114
2021 $22,120 $1,185 $326–$4,739 $132
2022 $23,258 $2,073 $554–$6,789 $149
2023 $25,266 $2,568 $759–$8,159 $160
2024 $13,917 $2,557 $703–$7,403 $164
2025 $25,297 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $52,832 104 payments
  2. Boston Scientific Corporation $40,453 86 payments
  3. Medtronic, Inc. $35,969 140 payments
  4. Abbott Laboratories $13,214 43 payments
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $9,624 7 payments
  6. Medtronic Vascular, Inc. $6,283 34 payments
  7. AltaThera Pharmaceuticals LLC $2,644 4 payments
  8. Biotronik Inc. $2,260 18 payments
  9. Impulse Dynamics (USA) Inc. $1,761 10 payments
  10. Biosense Webster, Inc. $906 14 payments
  11. Other $2,361 80 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $81,833 59 payments
  2. Consulting Fee $49,299 35 payments
  3. Food and Beverage $20,691 384 payments
  4. Travel and Lodging $14,721 60 payments
  5. Honoraria $1,750 1 payment
  6. Education $14 1 payment
Products named General payments · program years 2019–2025
  1. LifeVest $52,832 104 payments
  2. Ensite Cardiac Mapping System $11,799 23 payments
  3. PRADAXA $9,624 7 payments
  4. General - Therapies General - Therapies_CRM $8,504 10 payments
  5. FARAPULSE $5,948 6 payments
  6. General - Therapies Therapies $5,317 8 payments
  7. General Therapies $4,227 4 payments
  8. Arctic Front $3,759 15 payments
  9. General - Therapies General - Therapies_EP $3,000 1 payment
  10. Sotalol Hydrochloride $2,644 4 payments
  11. Other $21,534 298 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 25 drugs

Part D claims

1,051

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$394,875

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

40.2%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 197 $223,825
Xarelto Rivaroxaban Brand 53 $67,533
Multaq Dronedarone Hcl Brand 55 $60,356
Entresto Sacubitril/Valsartan Brand 21 $27,555
Dofetilide Generic 32 $5,253
Diltiazem 12hr Er Diltiazem Hcl Brand 14 $2,025
Metoprolol Succinate Generic 93 $1,123
Sotalol Sotalol Hcl Brand 37 $1,034
Flecainide Acetate Generic 39 $1,027
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 32 $1,026

The 10 drugs with the highest cost, of 25 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$248,282

Medicare's payments for the services billed

Medicare patients

781

Average age 77

Services billed

3,961

331 women, 450 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 67%
Ischemic heart disease 50%
Heart failure 46%
Arthritis 46%
Diabetes 34%
Chronic kidney disease 33%
Depression 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Sotalol Hydrochloride
  • AltaThera Pharmaceuticals LLC $600
$600 37 —
ELIQUIS
  • PFIZER INC. $72
  • E.R. Squibb & Sons, L.L.C. $28
$100 197 —
CAMZYOS
  • E.R. Squibb & Sons, L.L.C. $46
$46 — —
XARELTO
  • Janssen Pharmaceuticals, Inc $30
$30 53 —
PAXLOVID
  • PFIZER INC. $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

540 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record